Skip to main content
PharmSpace

Class Explorer · Respiratory

Inhaled corticosteroids

Topical anti-inflammatory therapy delivered to the airway, with high first-pass metabolism of whatever is swallowed so that systemic exposure stays low.

Members

Also in this class: Budesonide · Beclomethasone · Ciclesonide. Full pages arrive as the library grows.

Compare the members

Fluticasone
Role
Controller, alone or in combination
Note
Rinse after use; check technique

Shared across the class

Indications
Asthma, in every patient beyond the mildest · COPD in selected patients with exacerbations or eosinophilia
Adverse effects
Oral candidiasis · Dysphonia · Pneumonia risk in COPD · Systemic effects at high dose
Contraindications
Untreated respiratory tract infection, relative
Monitoring
Symptom control and exacerbation frequency · Inhaler technique at every single visit, because it is the commonest reason a regimen 'fails' · Mouth for candidiasis · Growth in children on long-term therapy

What makes each agent different

  • Potency per microgram differs enough that doses are not interchangeable between molecules; equivalence tables exist for a reason.
  • Ciclesonide is a prodrug activated in the lung, which reduces oropharyngeal effects.

Asthma is an inflammatory disease, so a patient using a reliever three or more times a week is under-treated on the controller, not under-supplied with the reliever. Short-acting-only asthma treatment is now considered unsafe.

Rinse and spit after every dose. Most candidiasis is a technique problem, not a drug problem.

Last reviewed 2026-08-16 · Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed.